Skip to content

Jade Biosciences

US · JBIO #3338 by market cap Listed 2021
13.77 +0.36 +2.68%
Live - 5344 symbols - heartbeat 298s ago · 2026-10-08 08:46
Pre-market 13.30 -3.41%
After-hours 13.00 -5.59%
Market cap
875.74M
P/B
1.99
EPS
-3.19
Reader sentiment Are you bullish or bearish on JBIO?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • H.C. Wainwright Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $55
    Market Newswire · 2026/10/1
  • Rating change
    Jefferies Maintains Jade Biosciences(JBIO.US) With Buy Rating, Raises Target Price to $48
    Market Newswire · 2026/8/12
  • Rating change
    A Quick Look at Today's Ratings for Jade Biosciences(JBIO.US), With a Forecast Between $40 to $74
    Market Newswire · 2026/6/2
  • Rating change
    UBS Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/6/15
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Sagimet Biosciences, Inc. Class A (SGMT) and Jade Biosciences (JBIO)
    TipRanks · 2026/10/1
  • William Blair Maintains Jade Biosciences(JBIO.US) With Buy Rating
    Market Newswire · 2026/10/1
  • Rating change
    Clear Street Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $48
    Market Newswire · 2026/9/4
  • Rating change
    UBS Initiates Jade Biosciences(JBIO.US) With Buy Rating, Announces Target Price $45
    Market Newswire · 2026/6/15
  • Rating change
    Wedbush Maintains Jade Biosciences(JBIO.US) With Buy Rating, Raises Target Price to $45
    Market Newswire · 2026/6/2
  • Rating change
    Stifel Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/8/14
  • Rating change
    Guggenheim Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $32
    Market Newswire · 2026/5/27
  • LifeSci Capital Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $42
    Market Newswire · 2026/10/1
  • Rating change
    Guggenheim Maintains Jade Biosciences(JBIO.US) With Buy Rating, Raises Target Price to $32
    Market Newswire · 2026/5/11
  • Rating change
    A Quick Look at Today's Ratings for Jade Biosciences(JBIO.US), With a Forecast Between $42 to $77
    Market Newswire · 2026/8/11
  • Guggenheim Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $47
    Market Newswire · 2026/10/2
  • Rating change
    Wedbush Maintains Jade Biosciences(JBIO.US) With Buy Rating, Announces Target Price $47
    Market Newswire · 2026/8/11
  • Rating change
    Clear Street Maintains Jade Biosciences(JBIO.US) With Buy Rating, Raises Target Price to $48
    Market Newswire · 2026/9/4
  • Wedbush Initiates Jade Biosciences(JBIO.US) With Buy Rating, Announces Target Price $47
    Market Newswire · 2026/10/1
  • Rating change
    BTIG Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $39
    Market Newswire · 2026/5/27
  • Rating change
    H.C. Wainwright Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/5/12

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 08:46:53 · For reference only, not investment advice and not tailored to your situation.